Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
32401
32402
32403
32404
32405
32406
32407
32408
32409
32410
32411
32412
32413
32414
32415
32416
32417
32418
32419
32420
32421
32422
32423
32424
32425
32426
32427
32428
32429
32430
32431
32432
32433
32434
32435
32436
32437
32438
32439
32440
32441
32442
32443
32444
32445
32446
32447
32448
32449
32450
32451
32452
32453
32454
32455
32456
32457
32458
32459
32460
32461
32462
32463
32464
32465
32466
32467
32468
32469
32470
32471
32472
32473
32474
32475
32476
32477
32478
32479
32480
32481
32482
32483
32484
32485
32486
32487
32488
32489
32490
32491
32492
32493
32494
32495
32496
32497
32498
32499
32500
32501
32502
32503
32504
32505
32506
32507
32508
32509
32510
32511
32512
32513
32514
32515
32516
32517
32518
32519
32520
32521
32522
32523
32524
32525
32526
32527
32528
32529
32530
32531
32532
32533
32534
32535
32536
32537
32538
32539
32540
32541
32542
32543
32544
32545
32546
32547
32548
32549
32550
32551
32552
32553
32554
32555
32556
32557
32558
32559
32560
32561
32562
32563
32564
32565
32566
32567
32568
32569
32570
32571
32572
32573
32574
32575
32576
32577
32578
32579
32580
32581
32582
32583
32584
32585
32586
32587
32588
32589
32590
32591
32592
32593
32594
32595
32596
32597
32598
32599
32600
| UnnamedSample_HQ_transcript/3128|m.1494 | UnnamedSample_HQ_transcript/3128 | Coverage 0.158 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 285 | 459 | 4.5E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/3128|m.1494 | UnnamedSample_HQ_transcript/3128 | Coverage 0.158 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 115 | 184 | 6.6E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/8354|m.3308 | UnnamedSample_HQ_transcript/8354 | Coverage 0.196 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 285 | 459 | 4.5E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/8354|m.3308 | UnnamedSample_HQ_transcript/8354 | Coverage 0.196 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 115 | 184 | 6.6E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/14735|m.5335 | UnnamedSample_HQ_transcript/14735 | Coverage 0.089 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 285 | 459 | 4.5E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/14735|m.5335 | UnnamedSample_HQ_transcript/14735 | Coverage 0.089 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 115 | 184 | 6.6E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/8934|m.3492 | UnnamedSample_HQ_transcript/8934 | Coverage 0.200 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 285 | 459 | 4.5E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/8934|m.3492 | UnnamedSample_HQ_transcript/8934 | Coverage 0.200 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 115 | 184 | 6.6E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/12339|m.4601 | UnnamedSample_HQ_transcript/12339 | Coverage 0.216 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 285 | 459 | 4.5E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/12339|m.4601 | UnnamedSample_HQ_transcript/12339 | Coverage 0.216 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 115 | 184 | 6.6E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/2663|m.1304 | UnnamedSample_HQ_transcript/2663 | Coverage 0.152 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 285 | 459 | 4.5E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/2663|m.1304 | UnnamedSample_HQ_transcript/2663 | Coverage 0.152 too low. | 40924a36c622df4355dc59ac8aa65a56 | 1067 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 115 | 184 | 6.6E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/21866|m.7389 | UnnamedSample_HQ_transcript/21866 | Coverage 0.923 too low. | 1b9950f3ff7228974397e4ff05ae0ff7 | 871 | Pfam | PF11838 | ERAP1-like C-terminal domain | 535 | 849 | 5.5E-75 | T | 22-09-2020 | IPR024571 | ERAP1-like C-terminal domain |
| UnnamedSample_HQ_transcript/21866|m.7389 | UnnamedSample_HQ_transcript/21866 | Coverage 0.923 too low. | 1b9950f3ff7228974397e4ff05ae0ff7 | 871 | Pfam | PF01433 | Peptidase family M1 domain | 237 | 454 | 7.3E-83 | T | 22-09-2020 | IPR014782 | Peptidase M1, membrane alanine aminopeptidase |
| UnnamedSample_HQ_transcript/21866|m.7389 | UnnamedSample_HQ_transcript/21866 | Coverage 0.923 too low. | 1b9950f3ff7228974397e4ff05ae0ff7 | 871 | Pfam | PF17900 | Peptidase M1 N-terminal domain | 16 | 202 | 1.7E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/75933|m.19006 | UnnamedSample_HQ_transcript/75933 | Coverage 0.626 too low. | e8335cbda7655be52fb3e2f9534ebfb2 | 279 | Pfam | PF06775 | Putative adipose-regulatory protein (Seipin) | 52 | 253 | 1.9E-54 | T | 22-09-2020 | IPR009617 | Seipin family |
| UnnamedSample_HQ_transcript/14078|m.5130 | UnnamedSample_HQ_transcript/14078 | Identity 0.837 too low. | 5510205e2b14489c1f87c966d6e4b5d1 | 724 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 401 | 658 | 8.3E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/9422|m.3646 | UnnamedSample_HQ_transcript/9422 | Identity 0.836 too low. | 5510205e2b14489c1f87c966d6e4b5d1 | 724 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 401 | 658 | 8.3E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/5335|m.2313 | UnnamedSample_HQ_transcript/5335 | Identity 0.846 too low. | 5510205e2b14489c1f87c966d6e4b5d1 | 724 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 401 | 658 | 8.3E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/22976|m.7682 | UnnamedSample_HQ_transcript/22976 | Identity 0.808 too low. | 5510205e2b14489c1f87c966d6e4b5d1 | 724 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 401 | 658 | 8.3E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/108578|m.23654 | UnnamedSample_HQ_transcript/108578 | Coverage 0.986 too low. | 05b7d97e5a48c809a5e940ae80df6d05 | 259 | Pfam | PF00227 | Proteasome subunit | 29 | 215 | 1.9E-57 | T | 22-09-2020 | IPR001353 | Proteasome, subunit alpha/beta |
| UnnamedSample_HQ_transcript/108578|m.23654 | UnnamedSample_HQ_transcript/108578 | Coverage 0.986 too low. | 05b7d97e5a48c809a5e940ae80df6d05 | 259 | Pfam | PF10584 | Proteasome subunit A N-terminal signature | 5 | 27 | 1.1E-13 | T | 22-09-2020 | IPR000426 | Proteasome alpha-subunit, N-terminal domain |
| UnnamedSample_HQ_transcript/61955|m.16438 | UnnamedSample_HQ_transcript/61955 | Identity 0.707 too low. | a50ef3add9cc387491f70897d009511c | 466 | Pfam | PF00412 | LIM domain | 149 | 203 | 3.5E-14 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/61955|m.16438 | UnnamedSample_HQ_transcript/61955 | Identity 0.707 too low. | a50ef3add9cc387491f70897d009511c | 466 | Pfam | PF00412 | LIM domain | 87 | 143 | 1.0E-15 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/61955|m.16438 | UnnamedSample_HQ_transcript/61955 | Identity 0.707 too low. | a50ef3add9cc387491f70897d009511c | 466 | Pfam | PF00046 | Homeodomain | 351 | 407 | 3.9E-18 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/92539|m.21603 | UnnamedSample_HQ_transcript/92539 | Coverage 0.340 too low. | 0a29041d9ce013503350177b2533e55a | 418 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 122 | 418 | 6.3E-65 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/60811|m.16220 | UnnamedSample_HQ_transcript/60811 | Coverage 0.803 too low. | 506acda673f09f3a61b6ed442f3cbfd0 | 552 | Pfam | PF00498 | FHA domain | 294 | 370 | 1.2E-12 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/60811|m.16220 | UnnamedSample_HQ_transcript/60811 | Coverage 0.803 too low. | 506acda673f09f3a61b6ed442f3cbfd0 | 552 | Pfam | PF01585 | G-patch domain | 474 | 517 | 7.3E-15 | T | 22-09-2020 | IPR000467 | G-patch domain |
| UnnamedSample_HQ_transcript/60811|m.16220 | UnnamedSample_HQ_transcript/60811 | Coverage 0.803 too low. | 506acda673f09f3a61b6ed442f3cbfd0 | 552 | Pfam | PF17780 | OCRE domain | 114 | 164 | 1.7E-16 | T | 22-09-2020 | IPR041591 | OCRE domain |
| UnnamedSample_HQ_transcript/14349|m.5214 | UnnamedSample_HQ_transcript/14349 | Unmapped. | 2aefd45604e16cd855418bae21dfe40a | 1151 | Pfam | PF17222 | Viral cysteine endopeptidase C107 | 195 | 450 | 4.0E-11 | T | 22-09-2020 | IPR033777 | Viral cysteine endopeptidase C107 |
| UnnamedSample_HQ_transcript/97805|m.22337 | UnnamedSample_HQ_transcript/97805 | Coverage 0.981 too low. | fbcafaf6bc616be8bf8b82cbef2c3f6f | 179 | Pfam | PF00134 | Cyclin, N-terminal domain | 50 | 172 | 1.6E-11 | T | 22-09-2020 | IPR006671 | Cyclin, N-terminal |
| UnnamedSample_HQ_transcript/2075|m.1088 | UnnamedSample_HQ_transcript/2075 | Coverage 0.558 too low. | e6e39cb23380140cec957e2d4bd074d8 | 1754 | Pfam | PF00567 | Tudor domain | 914 | 1017 | 4.5E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/2075|m.1088 | UnnamedSample_HQ_transcript/2075 | Coverage 0.558 too low. | e6e39cb23380140cec957e2d4bd074d8 | 1754 | Pfam | PF00567 | Tudor domain | 1616 | 1700 | 2.6E-9 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/2075|m.1088 | UnnamedSample_HQ_transcript/2075 | Coverage 0.558 too low. | e6e39cb23380140cec957e2d4bd074d8 | 1754 | Pfam | PF00567 | Tudor domain | 1375 | 1493 | 6.0E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/2075|m.1088 | UnnamedSample_HQ_transcript/2075 | Coverage 0.558 too low. | e6e39cb23380140cec957e2d4bd074d8 | 1754 | Pfam | PF00567 | Tudor domain | 381 | 491 | 1.5E-6 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/2075|m.1088 | UnnamedSample_HQ_transcript/2075 | Coverage 0.558 too low. | e6e39cb23380140cec957e2d4bd074d8 | 1754 | Pfam | PF00567 | Tudor domain | 588 | 696 | 1.9E-13 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/2075|m.1088 | UnnamedSample_HQ_transcript/2075 | Coverage 0.558 too low. | e6e39cb23380140cec957e2d4bd074d8 | 1754 | Pfam | PF00567 | Tudor domain | 791 | 871 | 2.8E-10 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/48507|m.13696 | UnnamedSample_HQ_transcript/48507 | Coverage 0.832 too low. | bc3a6c4db8e6f8512cfc4c3fd3f50d23 | 323 | Pfam | PF00557 | Metallopeptidase family M24 | 86 | 315 | 8.1E-44 | T | 22-09-2020 | IPR000994 | Peptidase M24 |
| UnnamedSample_HQ_transcript/119327|m.24801 | UnnamedSample_HQ_transcript/119327 | Coverage 0.989 too low. | f670c42e9fac46be9a4dda53c074c789 | 127 | Pfam | PF10210 | Mitochondrial 28S ribosomal protein S32 | 34 | 122 | 3.3E-34 | T | 22-09-2020 | IPR019346 | 39S ribosomal protein L42, mitochondrial |
| UnnamedSample_HQ_transcript/121566|m.24964 | UnnamedSample_HQ_transcript/121566 | Coverage 0.951 too low. | f670c42e9fac46be9a4dda53c074c789 | 127 | Pfam | PF10210 | Mitochondrial 28S ribosomal protein S32 | 34 | 122 | 3.3E-34 | T | 22-09-2020 | IPR019346 | 39S ribosomal protein L42, mitochondrial |
| UnnamedSample_HQ_transcript/19437|m.6712 | UnnamedSample_HQ_transcript/19437 | Coverage 0.772 too low. | e49e336fcc5f1142bbe44955781e1c47 | 958 | Pfam | PF13976 | GAG-pre-integrase domain | 105 | 158 | 2.8E-8 | T | 22-09-2020 | IPR025724 | GAG-pre-integrase domain |
| UnnamedSample_HQ_transcript/19437|m.6712 | UnnamedSample_HQ_transcript/19437 | Coverage 0.772 too low. | e49e336fcc5f1142bbe44955781e1c47 | 958 | Pfam | PF07727 | Reverse transcriptase (RNA-dependent DNA polymerase) | 486 | 719 | 1.4E-59 | T | 22-09-2020 | IPR013103 | Reverse transcriptase, RNA-dependent DNA polymerase |
| UnnamedSample_HQ_transcript/19437|m.6712 | UnnamedSample_HQ_transcript/19437 | Coverage 0.772 too low. | e49e336fcc5f1142bbe44955781e1c47 | 958 | Pfam | PF00665 | Integrase core domain | 174 | 271 | 2.2E-10 | T | 22-09-2020 | IPR001584 | Integrase, catalytic core |
| UnnamedSample_HQ_transcript/11758|m.4413 | UnnamedSample_HQ_transcript/11758 | Identity 0.945 too low. | 8f59f317334d25b763f97988b26df5e9 | 462 | Pfam | PF00075 | RNase H | 170 | 315 | 6.0E-22 | T | 22-09-2020 | IPR002156 | Ribonuclease H domain |
| UnnamedSample_HQ_transcript/70178|m.17953 | UnnamedSample_HQ_transcript/70178 | Identity 0.949 too low. | 095d2270642c7a7e79559a4c099c1461 | 324 | Pfam | PF00012 | Hsp70 protein | 10 | 217 | 6.4E-99 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/70178|m.17953 | UnnamedSample_HQ_transcript/70178 | Identity 0.949 too low. | 095d2270642c7a7e79559a4c099c1461 | 324 | Pfam | PF00226 | DnaJ domain | 261 | 298 | 2.4E-12 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/3406|m.1593 | UnnamedSample_HQ_transcript/3406 | Coverage 0.787 too low. | f66162a3de890bde81b1766f22209da0 | 1343 | Pfam | PF17908 | APAF-1 helical domain | 470 | 603 | 1.7E-29 | T | 22-09-2020 | IPR041452 | APAF-1 helical domain |
| UnnamedSample_HQ_transcript/3406|m.1593 | UnnamedSample_HQ_transcript/3406 | Coverage 0.787 too low. | f66162a3de890bde81b1766f22209da0 | 1343 | Pfam | PF00400 | WD domain, G-beta repeat | 736 | 773 | 1.6E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/3406|m.1593 | UnnamedSample_HQ_transcript/3406 | Coverage 0.787 too low. | f66162a3de890bde81b1766f22209da0 | 1343 | Pfam | PF00619 | Caspase recruitment domain | 8 | 84 | 3.8E-9 | T | 22-09-2020 | IPR001315 | CARD domain |
| UnnamedSample_HQ_transcript/3406|m.1593 | UnnamedSample_HQ_transcript/3406 | Coverage 0.787 too low. | f66162a3de890bde81b1766f22209da0 | 1343 | Pfam | PF00931 | NB-ARC domain | 126 | 385 | 2.5E-21 | T | 22-09-2020 | IPR002182 | NB-ARC |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF13927 | Immunoglobulin domain | 466 | 538 | 6.4E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF13927 | Immunoglobulin domain | 241 | 307 | 2.4E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00052 | Laminin B (Domain IV) | 1379 | 1432 | 8.7E-9 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00052 | Laminin B (Domain IV) | 657 | 810 | 2.1E-19 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00052 | Laminin B (Domain IV) | 1040 | 1177 | 7.9E-35 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00053 | Laminin EGF domain | 1266 | 1309 | 0.024 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00053 | Laminin EGF domain | 811 | 833 | 0.029 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00053 | Laminin EGF domain | 1212 | 1257 | 1.0E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00053 | Laminin EGF domain | 1178 | 1200 | 0.0073 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00053 | Laminin EGF domain | 865 | 920 | 1.4E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00053 | Laminin EGF domain | 925 | 968 | 1.7E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 104 | 139 | 9.7E-11 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 422 | 460 | 1.3E-8 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 195 | 230 | 4.4E-8 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 379 | 414 | 4.5E-12 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 339 | 374 | 3.3E-11 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 24 | 58 | 3.9E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 153 | 187 | 5.9E-10 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/4967|m.2180 | UnnamedSample_HQ_transcript/4967 | Coverage 0.109 too low. | 06e19043be6efc6c51177dc76e47d043 | 1445 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 67 | 102 | 4.4E-10 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/27898|m.8938 | UnnamedSample_HQ_transcript/27898 | Coverage 0.050 too low. | 7d40cf5506cc9a39e7514a9b2265f336 | 802 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 157 | 762 | 3.8E-63 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/95759|m.22058 | UnnamedSample_HQ_transcript/95759 | Coverage 0.812 too low. | 8ea75c357cf2606adf6defe9ac44b104 | 326 | Pfam | PF00514 | Armadillo/beta-catenin-like repeat | 284 | 323 | 7.9E-10 | T | 22-09-2020 | IPR000225 | Armadillo |
| UnnamedSample_HQ_transcript/1325|m.775 | UnnamedSample_HQ_transcript/1325 | Coverage 0.246 too low. | 3874bb352d81ab41af64b8a863503dec | 1520 | Pfam | PF01839 | FG-GAP repeat | 305 | 345 | 3.1E-10 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/1325|m.775 | UnnamedSample_HQ_transcript/1325 | Coverage 0.246 too low. | 3874bb352d81ab41af64b8a863503dec | 1520 | Pfam | PF01839 | FG-GAP repeat | 383 | 426 | 1.9E-6 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/1325|m.775 | UnnamedSample_HQ_transcript/1325 | Coverage 0.246 too low. | 3874bb352d81ab41af64b8a863503dec | 1520 | Pfam | PF08441 | Integrin alpha | 492 | 933 | 1.4E-74 | T | 22-09-2020 | IPR013649 | Integrin alpha-2 |
| UnnamedSample_HQ_transcript/2111|m.1099 | UnnamedSample_HQ_transcript/2111 | Coverage 0.326 too low. | 3874bb352d81ab41af64b8a863503dec | 1520 | Pfam | PF01839 | FG-GAP repeat | 305 | 345 | 3.1E-10 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/2111|m.1099 | UnnamedSample_HQ_transcript/2111 | Coverage 0.326 too low. | 3874bb352d81ab41af64b8a863503dec | 1520 | Pfam | PF01839 | FG-GAP repeat | 383 | 426 | 1.9E-6 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/2111|m.1099 | UnnamedSample_HQ_transcript/2111 | Coverage 0.326 too low. | 3874bb352d81ab41af64b8a863503dec | 1520 | Pfam | PF08441 | Integrin alpha | 492 | 933 | 1.4E-74 | T | 22-09-2020 | IPR013649 | Integrin alpha-2 |
| UnnamedSample_HQ_transcript/1010|m.630 | UnnamedSample_HQ_transcript/1010 | Coverage 0.284 too low. | 3874bb352d81ab41af64b8a863503dec | 1520 | Pfam | PF01839 | FG-GAP repeat | 305 | 345 | 3.1E-10 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/1010|m.630 | UnnamedSample_HQ_transcript/1010 | Coverage 0.284 too low. | 3874bb352d81ab41af64b8a863503dec | 1520 | Pfam | PF01839 | FG-GAP repeat | 383 | 426 | 1.9E-6 | T | 22-09-2020 | IPR013517 | FG-GAP repeat |
| UnnamedSample_HQ_transcript/1010|m.630 | UnnamedSample_HQ_transcript/1010 | Coverage 0.284 too low. | 3874bb352d81ab41af64b8a863503dec | 1520 | Pfam | PF08441 | Integrin alpha | 492 | 933 | 1.4E-74 | T | 22-09-2020 | IPR013649 | Integrin alpha-2 |
| UnnamedSample_HQ_transcript/35367|m.10793 | UnnamedSample_HQ_transcript/35367 | Coverage 0.914 too low. | be04fca67fa1f78f01c88b9fd28ce945 | 640 | Pfam | PF00784 | MyTH4 domain | 316 | 434 | 1.0E-26 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/35367|m.10793 | UnnamedSample_HQ_transcript/35367 | Coverage 0.914 too low. | be04fca67fa1f78f01c88b9fd28ce945 | 640 | Pfam | PF00620 | RhoGAP domain | 471 | 607 | 4.8E-30 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/62327|m.16512 | UnnamedSample_HQ_transcript/62327 | Coverage 0.698 too low. | 4946b50105ee55ef6a6fcfc6c4619fa0 | 260 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 54 | 105 | 1.8E-10 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/64901|m.17016 | UnnamedSample_HQ_transcript/64901 | Coverage 0.676 too low. | 4946b50105ee55ef6a6fcfc6c4619fa0 | 260 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 54 | 105 | 1.8E-10 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/54596|m.14965 | UnnamedSample_HQ_transcript/54596 | Coverage 0.469 too low. | d491ba9b5d1a86e12f1c1f2554a3b9bf | 185 | Pfam | PF01431 | Peptidase family M13 | 37 | 160 | 6.6E-46 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/14376|m.5225 | UnnamedSample_HQ_transcript/14376 | Identity 0.670 too low. | d63b5ca65871cfef9fa4b13a85ca02a8 | 410 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 1 | 406 | 8.6E-18 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/79612|m.19644 | UnnamedSample_HQ_transcript/79612 | Coverage 0.267 too low. | 2632c85a21ec3564eef8a991d0763dad | 412 | Pfam | PF00067 | Cytochrome P450 | 12 | 393 | 8.5E-71 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/80387|m.19781 | UnnamedSample_HQ_transcript/80387 | Coverage 0.298 too low. | 2632c85a21ec3564eef8a991d0763dad | 412 | Pfam | PF00067 | Cytochrome P450 | 12 | 393 | 8.5E-71 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/8033|m.3196 | UnnamedSample_HQ_transcript/8033 | Coverage 0.908 too low. | a5395d249b17cc25d13ef25cb9cf5a35 | 1066 | Pfam | PF07748 | Glycosyl hydrolases family 38 C-terminal domain | 684 | 886 | 1.8E-29 | T | 22-09-2020 | IPR011682 | Glycosyl hydrolase family 38, C-terminal |
| UnnamedSample_HQ_transcript/8033|m.3196 | UnnamedSample_HQ_transcript/8033 | Coverage 0.908 too low. | a5395d249b17cc25d13ef25cb9cf5a35 | 1066 | Pfam | PF01074 | Glycosyl hydrolases family 38 N-terminal domain | 88 | 412 | 5.9E-99 | T | 22-09-2020 | IPR000602 | Glycoside hydrolase family 38, N-terminal domain |
| UnnamedSample_HQ_transcript/8033|m.3196 | UnnamedSample_HQ_transcript/8033 | Coverage 0.908 too low. | a5395d249b17cc25d13ef25cb9cf5a35 | 1066 | Pfam | PF09261 | Alpha mannosidase middle domain | 418 | 522 | 5.3E-24 | T | 22-09-2020 | IPR015341 | Glycoside hydrolase family 38, central domain |
| UnnamedSample_HQ_transcript/22184|m.7483 | UnnamedSample_HQ_transcript/22184 | Identity 0.882 too low. | 7e744b267034f1aed253a6dc46a76e98 | 871 | Pfam | PF15296 | Codanin-1 C-terminus | 490 | 591 | 3.8E-13 | T | 22-09-2020 | IPR028171 | Codanin-1, C-terminal domain |
| UnnamedSample_HQ_transcript/31181|m.9756 | UnnamedSample_HQ_transcript/31181 | Coverage 0.966 too low. | 165323c0992fa44340810554c3a182c3 | 481 | Pfam | PF13246 | Cation transport ATPase (P-type) | 11 | 58 | 8.8E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/31181|m.9756 | UnnamedSample_HQ_transcript/31181 | Coverage 0.966 too low. | 165323c0992fa44340810554c3a182c3 | 481 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 293 | 464 | 1.2E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/31181|m.9756 | UnnamedSample_HQ_transcript/31181 | Coverage 0.966 too low. | 165323c0992fa44340810554c3a182c3 | 481 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 77 | 222 | 3.3E-15 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/34284|m.10542 | UnnamedSample_HQ_transcript/34284 | Coverage 0.964 too low. | 165323c0992fa44340810554c3a182c3 | 481 | Pfam | PF13246 | Cation transport ATPase (P-type) | 11 | 58 | 8.8E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/34284|m.10542 | UnnamedSample_HQ_transcript/34284 | Coverage 0.964 too low. | 165323c0992fa44340810554c3a182c3 | 481 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 293 | 464 | 1.2E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/34284|m.10542 | UnnamedSample_HQ_transcript/34284 | Coverage 0.964 too low. | 165323c0992fa44340810554c3a182c3 | 481 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 77 | 222 | 3.3E-15 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/16108|m.5743 | UnnamedSample_HQ_transcript/16108 | Coverage 0.039 too low. | 0f6ac253618a7bcfcc39da4d4475e3e1 | 708 | Pfam | PF00567 | Tudor domain | 479 | 597 | 1.4E-19 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16108|m.5743 | UnnamedSample_HQ_transcript/16108 | Coverage 0.039 too low. | 0f6ac253618a7bcfcc39da4d4475e3e1 | 708 | Pfam | PF00565 | Staphylococcal nuclease homologue | 47 | 130 | 1.2E-6 | T | 22-09-2020 | IPR016071 | Staphylococcal nuclease (SNase-like), OB-fold |
| UnnamedSample_HQ_transcript/16108|m.5743 | UnnamedSample_HQ_transcript/16108 | Coverage 0.039 too low. | 0f6ac253618a7bcfcc39da4d4475e3e1 | 708 | Pfam | PF00565 | Staphylococcal nuclease homologue | 353 | 458 | 6.8E-17 | T | 22-09-2020 | IPR016071 | Staphylococcal nuclease (SNase-like), OB-fold |
| UnnamedSample_HQ_transcript/16108|m.5743 | UnnamedSample_HQ_transcript/16108 | Coverage 0.039 too low. | 0f6ac253618a7bcfcc39da4d4475e3e1 | 708 | Pfam | PF00565 | Staphylococcal nuclease homologue | 166 | 296 | 1.0E-11 | T | 22-09-2020 | IPR016071 | Staphylococcal nuclease (SNase-like), OB-fold |
| UnnamedSample_HQ_transcript/60678|m.16195 | UnnamedSample_HQ_transcript/60678 | Coverage 0.495 too low. | 6eb0895c529d612668888003bcd99cb0 | 532 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 126 | 510 | 4.0E-91 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/55838|m.15198 | UnnamedSample_HQ_transcript/55838 | Coverage 0.512 too low. | 6eb0895c529d612668888003bcd99cb0 | 532 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 126 | 510 | 4.0E-91 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/51306|m.14309 | UnnamedSample_HQ_transcript/51306 | Coverage 0.084 too low. | dc3bcfe9566b9097927046fda28296ac | 650 | Pfam | PF02961 | Barrier to autointegration factor | 569 | 647 | 1.7E-14 | T | 22-09-2020 | IPR004122 | Barrier- to-autointegration factor, BAF |
| UnnamedSample_HQ_transcript/55714|m.15178 | UnnamedSample_HQ_transcript/55714 | Coverage 0.057 too low. | dc3bcfe9566b9097927046fda28296ac | 650 | Pfam | PF02961 | Barrier to autointegration factor | 569 | 647 | 1.7E-14 | T | 22-09-2020 | IPR004122 | Barrier- to-autointegration factor, BAF |
| UnnamedSample_HQ_transcript/32828|m.10173 | UnnamedSample_HQ_transcript/32828 | Coverage 0.890 too low. | 251d64f0a876e3e3e58bbd4a9747a3eb | 715 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 43 | 161 | 1.4E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/32828|m.10173 | UnnamedSample_HQ_transcript/32828 | Coverage 0.890 too low. | 251d64f0a876e3e3e58bbd4a9747a3eb | 715 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 386 | 574 | 2.0E-6 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/101100|m.22762 | UnnamedSample_HQ_transcript/101100 | Coverage 0.986 too low. | 1faf1967be724ae03621cd8123e70bfb | 370 | Pfam | PF03366 | YEATS family | 28 | 108 | 1.2E-24 | T | 22-09-2020 | IPR005033 | YEATS |
| UnnamedSample_HQ_transcript/110677|m.23923 | UnnamedSample_HQ_transcript/110677 | Coverage 0.989 too low. | 46cff810909c4f327cb0012cebefebd4 | 120 | Pfam | PF01161 | Phosphatidylethanolamine-binding protein | 1 | 102 | 6.1E-16 | T | 22-09-2020 | IPR008914 | Phosphatidylethanolamine-binding protein |
| UnnamedSample_HQ_transcript/80|m.80 | UnnamedSample_HQ_transcript/80 | Unmapped. | 1efdf24f3c128074853d72f1217e302c | 966 | Pfam | PF13086 | AAA domain | 269 | 339 | 4.2E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/80|m.80 | UnnamedSample_HQ_transcript/80 | Unmapped. | 1efdf24f3c128074853d72f1217e302c | 966 | Pfam | PF13087 | AAA domain | 452 | 623 | 6.9E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/7898|m.3154 | UnnamedSample_HQ_transcript/7898 | Coverage 0.169 too low. | a0d1ccc4e11027c1bee5319e3d02b02d | 575 | Pfam | PF02403 | Seryl-tRNA synthetase N-terminal domain | 3 | 94 | 3.3E-18 | T | 22-09-2020 | IPR015866 | Serine-tRNA synthetase, type1, N-terminal |
| UnnamedSample_HQ_transcript/7898|m.3154 | UnnamedSample_HQ_transcript/7898 | Coverage 0.169 too low. | a0d1ccc4e11027c1bee5319e3d02b02d | 575 | Pfam | PF00587 | tRNA synthetase class II core domain (G, H, P, S and T) | 340 | 524 | 1.5E-40 | T | 22-09-2020 | IPR002314 | Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) |
| UnnamedSample_HQ_transcript/49071|m.13818 | UnnamedSample_HQ_transcript/49071 | Unmapped. | a0d1ccc4e11027c1bee5319e3d02b02d | 575 | Pfam | PF02403 | Seryl-tRNA synthetase N-terminal domain | 3 | 94 | 3.3E-18 | T | 22-09-2020 | IPR015866 | Serine-tRNA synthetase, type1, N-terminal |
| UnnamedSample_HQ_transcript/49071|m.13818 | UnnamedSample_HQ_transcript/49071 | Unmapped. | a0d1ccc4e11027c1bee5319e3d02b02d | 575 | Pfam | PF00587 | tRNA synthetase class II core domain (G, H, P, S and T) | 340 | 524 | 1.5E-40 | T | 22-09-2020 | IPR002314 | Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) |
| UnnamedSample_HQ_transcript/59066|m.15863 | UnnamedSample_HQ_transcript/59066 | Unmapped. | a0d1ccc4e11027c1bee5319e3d02b02d | 575 | Pfam | PF02403 | Seryl-tRNA synthetase N-terminal domain | 3 | 94 | 3.3E-18 | T | 22-09-2020 | IPR015866 | Serine-tRNA synthetase, type1, N-terminal |
| UnnamedSample_HQ_transcript/59066|m.15863 | UnnamedSample_HQ_transcript/59066 | Unmapped. | a0d1ccc4e11027c1bee5319e3d02b02d | 575 | Pfam | PF00587 | tRNA synthetase class II core domain (G, H, P, S and T) | 340 | 524 | 1.5E-40 | T | 22-09-2020 | IPR002314 | Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) |
| UnnamedSample_HQ_transcript/775|m.537 | UnnamedSample_HQ_transcript/775 | Coverage 0.808 too low. | 68ceacb6b2f8f98700b9d0299baaaa42 | 2083 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 45 | 136 | 4.0E-19 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/775|m.537 | UnnamedSample_HQ_transcript/775 | Coverage 0.808 too low. | 68ceacb6b2f8f98700b9d0299baaaa42 | 2083 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 239 | 349 | 1.5E-20 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/775|m.537 | UnnamedSample_HQ_transcript/775 | Coverage 0.808 too low. | 68ceacb6b2f8f98700b9d0299baaaa42 | 2083 | Pfam | PF00595 | PDZ domain | 1043 | 1123 | 1.1E-15 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/775|m.537 | UnnamedSample_HQ_transcript/775 | Coverage 0.808 too low. | 68ceacb6b2f8f98700b9d0299baaaa42 | 2083 | Pfam | PF01843 | DIL domain | 813 | 915 | 3.7E-30 | T | 22-09-2020 | IPR002710 | Dilute domain |
| UnnamedSample_HQ_transcript/775|m.537 | UnnamedSample_HQ_transcript/775 | Coverage 0.808 too low. | 68ceacb6b2f8f98700b9d0299baaaa42 | 2083 | Pfam | PF00498 | FHA domain | 428 | 485 | 4.5E-6 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/63428|m.16719 | UnnamedSample_HQ_transcript/63428 | Coverage 0.449 too low. | 240bba467941a61df3267348efd38faa | 374 | Pfam | PF00268 | Ribonucleotide reductase, small chain | 64 | 331 | 1.2E-113 | T | 22-09-2020 | IPR000358 | Ribonucleotide reductase small subunit family |
| UnnamedSample_HQ_transcript/53435|m.14727 | UnnamedSample_HQ_transcript/53435 | Coverage 0.421 too low. | 240bba467941a61df3267348efd38faa | 374 | Pfam | PF00268 | Ribonucleotide reductase, small chain | 64 | 331 | 1.2E-113 | T | 22-09-2020 | IPR000358 | Ribonucleotide reductase small subunit family |
| UnnamedSample_HQ_transcript/58890|m.15827 | UnnamedSample_HQ_transcript/58890 | Coverage 0.441 too low. | 240bba467941a61df3267348efd38faa | 374 | Pfam | PF00268 | Ribonucleotide reductase, small chain | 64 | 331 | 1.2E-113 | T | 22-09-2020 | IPR000358 | Ribonucleotide reductase small subunit family |
| UnnamedSample_HQ_transcript/22803|m.7641 | UnnamedSample_HQ_transcript/22803 | Identity 0.902 too low. | b52ad8339172e9c7db7b459e83248ebb | 570 | Pfam | PF00625 | Guanylate kinase | 233 | 412 | 8.3E-45 | T | 22-09-2020 | IPR008145 | Guanylate kinase/L-type calcium channel beta subunit |
| UnnamedSample_HQ_transcript/22803|m.7641 | UnnamedSample_HQ_transcript/22803 | Identity 0.902 too low. | b52ad8339172e9c7db7b459e83248ebb | 570 | Pfam | PF12052 | Voltage gated calcium channel subunit beta domain 4Aa N terminal | 33 | 69 | 3.8E-16 | T | 22-09-2020 | IPR000584 | Voltage-dependent calcium channel, L-type, beta subunit |
| UnnamedSample_HQ_transcript/97569|m.22312 | UnnamedSample_HQ_transcript/97569 | Identity 0.776 too low. | 411033e0ddd568f62638a91abab4ea4b | 249 | Pfam | PF02780 | Transketolase, C-terminal domain | 116 | 239 | 9.7E-39 | T | 22-09-2020 | IPR033248 | Transketolase, C-terminal domain |
| UnnamedSample_HQ_transcript/97569|m.22312 | UnnamedSample_HQ_transcript/97569 | Identity 0.776 too low. | 411033e0ddd568f62638a91abab4ea4b | 249 | Pfam | PF02779 | Transketolase, pyrimidine binding domain | 1 | 97 | 7.5E-23 | T | 22-09-2020 | IPR005475 | Transketolase-like, pyrimidine-binding domain |
| UnnamedSample_HQ_transcript/5625|m.2401 | UnnamedSample_HQ_transcript/5625 | Coverage 0.989 too low. | 2892f0b740d3d6089b7c6fb9d62256f4 | 953 | Pfam | PF01833 | IPT/TIG domain | 546 | 603 | 1.2E-5 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/5625|m.2401 | UnnamedSample_HQ_transcript/5625 | Coverage 0.989 too low. | 2892f0b740d3d6089b7c6fb9d62256f4 | 953 | Pfam | PF01833 | IPT/TIG domain | 243 | 333 | 2.8E-6 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/5625|m.2401 | UnnamedSample_HQ_transcript/5625 | Coverage 0.989 too low. | 2892f0b740d3d6089b7c6fb9d62256f4 | 953 | Pfam | PF01833 | IPT/TIG domain | 338 | 416 | 2.4E-11 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/5625|m.2401 | UnnamedSample_HQ_transcript/5625 | Coverage 0.989 too low. | 2892f0b740d3d6089b7c6fb9d62256f4 | 953 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 722 | 952 | 1.4E-82 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/58255|m.15705 | UnnamedSample_HQ_transcript/58255 | Coverage 0.068 too low. | 6ce5003a0706d316580126a5268edd0f | 213 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 87 | 173 | 3.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/100102|m.22658 | UnnamedSample_HQ_transcript/100102 | Coverage 0.989 too low. | 24a909b5b944704cc45850a483a47a65 | 366 | Pfam | PF01400 | Astacin (Peptidase family M12A) | 82 | 271 | 4.8E-50 | T | 22-09-2020 | IPR001506 | Peptidase M12A |
| UnnamedSample_HQ_transcript/39591|m.11760 | UnnamedSample_HQ_transcript/39591 | Identity 0.897 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/39591|m.11760 | UnnamedSample_HQ_transcript/39591 | Identity 0.897 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/47020|m.13369 | UnnamedSample_HQ_transcript/47020 | Identity 0.874 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/47020|m.13369 | UnnamedSample_HQ_transcript/47020 | Identity 0.874 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/62318|m.16511 | UnnamedSample_HQ_transcript/62318 | Identity 0.860 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/62318|m.16511 | UnnamedSample_HQ_transcript/62318 | Identity 0.860 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/64225|m.16894 | UnnamedSample_HQ_transcript/64225 | Identity 0.865 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/64225|m.16894 | UnnamedSample_HQ_transcript/64225 | Identity 0.865 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/58587|m.15775 | UnnamedSample_HQ_transcript/58587 | Identity 0.860 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/58587|m.15775 | UnnamedSample_HQ_transcript/58587 | Identity 0.860 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/77879|m.19353 | UnnamedSample_HQ_transcript/77879 | Identity 0.844 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/77879|m.19353 | UnnamedSample_HQ_transcript/77879 | Identity 0.844 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/86902|m.20784 | UnnamedSample_HQ_transcript/86902 | Identity 0.828 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/86902|m.20784 | UnnamedSample_HQ_transcript/86902 | Identity 0.828 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/51302|m.14308 | UnnamedSample_HQ_transcript/51302 | Identity 0.876 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/51302|m.14308 | UnnamedSample_HQ_transcript/51302 | Identity 0.876 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/52725|m.14589 | UnnamedSample_HQ_transcript/52725 | Identity 0.871 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/52725|m.14589 | UnnamedSample_HQ_transcript/52725 | Identity 0.871 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/54222|m.14882 | UnnamedSample_HQ_transcript/54222 | Identity 0.871 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/54222|m.14882 | UnnamedSample_HQ_transcript/54222 | Identity 0.871 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/4920|m.2161 | UnnamedSample_HQ_transcript/4920 | Coverage 0.032 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/4920|m.2161 | UnnamedSample_HQ_transcript/4920 | Coverage 0.032 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/57790|m.15612 | UnnamedSample_HQ_transcript/57790 | Identity 0.864 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 195 | 340 | 1.7E-48 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/57790|m.15612 | UnnamedSample_HQ_transcript/57790 | Identity 0.864 too low. | b3595bdc943e8bc69f451a25e4c7e86a | 353 | Pfam | PF01210 | NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus | 6 | 174 | 8.6E-51 | T | 22-09-2020 | IPR011128 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal |
| UnnamedSample_HQ_transcript/115158|m.24411 | UnnamedSample_HQ_transcript/115158 | Coverage 0.990 too low. | 9d4fc351cec5f866f2dd326628a2e5c0 | 236 | Pfam | PF00199 | Catalase | 28 | 236 | 1.4E-105 | T | 22-09-2020 | IPR011614 | Catalase core domain |
| UnnamedSample_HQ_transcript/20289|m.6947 | UnnamedSample_HQ_transcript/20289 | Coverage 0.580 too low. | d79b3463613fbdd21cb2fee95cb6e92d | 693 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 199 | 594 | 1.6E-67 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/23198|m.7737 | UnnamedSample_HQ_transcript/23198 | Coverage 0.606 too low. | d79b3463613fbdd21cb2fee95cb6e92d | 693 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 199 | 594 | 1.6E-67 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/77418|m.19274 | UnnamedSample_HQ_transcript/77418 | Coverage 0.341 too low. | 643b61afdce6ad4e1bfa970fe43c634a | 467 | Pfam | PF07766 | LETM1-like protein | 146 | 410 | 2.1E-103 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/38965|m.11619 | UnnamedSample_HQ_transcript/38965 | Coverage 0.925 too low. | e7fd4efdb7de4f4552a8ca7e605469ae | 192 | Pfam | PF05478 | Prominin | 8 | 168 | 1.8E-37 | T | 22-09-2020 | IPR008795 | Prominin |
| UnnamedSample_HQ_transcript/27856|m.8929 | UnnamedSample_HQ_transcript/27856 | Unmapped. | 4f3f6e4326d7732cb9031a6b0a02e94f | 971 | Pfam | PF08762 | CRPV capsid protein like | 623 | 833 | 4.1E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/44397|m.12793 | UnnamedSample_HQ_transcript/44397 | Coverage 0.101 too low. | bc5b5509e5bed2adb5c239c582edbcf8 | 315 | Pfam | PF00012 | Hsp70 protein | 1 | 313 | 1.7E-137 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/54480|m.14936 | UnnamedSample_HQ_transcript/54480 | Identity 0.514 too low. | 991eb8c7dc754db0ded0814a0d27cd67 | 574 | Pfam | PF08839 | DNA replication factor CDT1 like | 219 | 379 | 3.7E-39 | T | 22-09-2020 | IPR014939 | CDT1 Geminin-binding domain-like |
| UnnamedSample_HQ_transcript/54480|m.14936 | UnnamedSample_HQ_transcript/54480 | Identity 0.514 too low. | 991eb8c7dc754db0ded0814a0d27cd67 | 574 | Pfam | PF16679 | DNA replication factor Cdt1 C-terminal domain | 452 | 546 | 2.2E-22 | T | 22-09-2020 | IPR032054 | DNA replication factor Cdt1, C-terminal |
| UnnamedSample_HQ_transcript/12681|m.4722 | UnnamedSample_HQ_transcript/12681 | Coverage 0.732 too low. | 5409554b8757427380fe2299d88155fd | 1093 | Pfam | PF00780 | CNH domain | 786 | 1063 | 1.2E-61 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/12681|m.4722 | UnnamedSample_HQ_transcript/12681 | Coverage 0.732 too low. | 5409554b8757427380fe2299d88155fd | 1093 | Pfam | PF00069 | Protein kinase domain | 1 | 95 | 1.1E-8 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/75146|m.18871 | UnnamedSample_HQ_transcript/75146 | Coverage 0.750 too low. | 1d43a400641c3f31bf4c60a768b00910 | 443 | Pfam | PF00135 | Carboxylesterase family | 18 | 433 | 5.8E-122 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/85801|m.20623 | UnnamedSample_HQ_transcript/85801 | Coverage 0.723 too low. | 1d43a400641c3f31bf4c60a768b00910 | 443 | Pfam | PF00135 | Carboxylesterase family | 18 | 433 | 5.8E-122 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/61083|m.16276 | UnnamedSample_HQ_transcript/61083 | Coverage 0.795 too low. | 1d43a400641c3f31bf4c60a768b00910 | 443 | Pfam | PF00135 | Carboxylesterase family | 18 | 433 | 5.8E-122 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/45715|m.13079 | UnnamedSample_HQ_transcript/45715 | Coverage 0.924 too low. | 1e8eeb388d40d3112a0a39ea8317b814 | 511 | Pfam | PF03388 | Legume-like lectin family | 28 | 250 | 9.8E-88 | T | 22-09-2020 | IPR005052 | Legume-like lectin |
| UnnamedSample_HQ_transcript/56387|m.15315 | UnnamedSample_HQ_transcript/56387 | Coverage 0.968 too low. | 1e8eeb388d40d3112a0a39ea8317b814 | 511 | Pfam | PF03388 | Legume-like lectin family | 28 | 250 | 9.8E-88 | T | 22-09-2020 | IPR005052 | Legume-like lectin |
| UnnamedSample_HQ_transcript/41060|m.12075 | UnnamedSample_HQ_transcript/41060 | Coverage 0.894 too low. | 1e8eeb388d40d3112a0a39ea8317b814 | 511 | Pfam | PF03388 | Legume-like lectin family | 28 | 250 | 9.8E-88 | T | 22-09-2020 | IPR005052 | Legume-like lectin |
| UnnamedSample_HQ_transcript/48466|m.13691 | UnnamedSample_HQ_transcript/48466 | Coverage 0.958 too low. | 1e8eeb388d40d3112a0a39ea8317b814 | 511 | Pfam | PF03388 | Legume-like lectin family | 28 | 250 | 9.8E-88 | T | 22-09-2020 | IPR005052 | Legume-like lectin |
| UnnamedSample_HQ_transcript/108430|m.23636 | UnnamedSample_HQ_transcript/108430 | Coverage 0.767 too low. | 9f373792d4162e0e5a74b4cc57cbb97b | 197 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 86 | 127 | 6.9E-12 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/84072|m.20350 | UnnamedSample_HQ_transcript/84072 | Coverage 0.196 too low. | bd5ffbc9f50c71fb710da9414a918ab7 | 259 | Pfam | PF00069 | Protein kinase domain | 2 | 232 | 7.2E-42 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/96752|m.22194 | UnnamedSample_HQ_transcript/96752 | Coverage 0.195 too low. | bd5ffbc9f50c71fb710da9414a918ab7 | 259 | Pfam | PF00069 | Protein kinase domain | 2 | 232 | 7.2E-42 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/89995|m.21256 | UnnamedSample_HQ_transcript/89995 | Unmapped. | 68c41894283f09b12526ddab77d68dc5 | 441 | Pfam | PF00910 | RNA helicase | 14 | 122 | 8.8E-19 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/82088|m.20044 | UnnamedSample_HQ_transcript/82088 | Coverage 0.203 too low. | 36eb0176c455a193015dd9408b184923 | 502 | Pfam | PF02898 | Nitric oxide synthase, oxygenase domain | 80 | 441 | 5.9E-186 | T | 22-09-2020 | IPR004030 | Nitric oxide synthase, N-terminal |
| UnnamedSample_HQ_transcript/95681|m.22047 | UnnamedSample_HQ_transcript/95681 | Coverage 0.863 too low. | 5e183dd97a8c18ed68fbb68a90f158d4 | 308 | Pfam | PF06990 | Galactose-3-O-sulfotransferase | 29 | 247 | 1.0E-33 | T | 22-09-2020 | IPR009729 | Galactose-3-O-sulfotransferase |
| UnnamedSample_HQ_transcript/94884|m.21941 | UnnamedSample_HQ_transcript/94884 | Coverage 0.987 too low. | 4d94a377ac3a2aa394a9c6992ee3dd45 | 312 | Pfam | PF07200 | Modifier of rudimentary (Mod(r)) protein | 172 | 310 | 7.8E-25 | T | 22-09-2020 | IPR009851 | Modifier of rudimentary, Modr |
| UnnamedSample_HQ_transcript/116432|m.24529 | UnnamedSample_HQ_transcript/116432 | Coverage 0.959 too low. | 020c0c5e7fe39678154e14a47307aec8 | 183 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 1 | 181 | 2.2E-33 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/86441|m.20714 | UnnamedSample_HQ_transcript/86441 | Coverage 0.868 too low. | ea5e8a515e0acdcb7636d5c617f34265 | 387 | Pfam | PF00732 | GMC oxidoreductase | 5 | 122 | 1.6E-33 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/86441|m.20714 | UnnamedSample_HQ_transcript/86441 | Coverage 0.868 too low. | ea5e8a515e0acdcb7636d5c617f34265 | 387 | Pfam | PF05199 | GMC oxidoreductase | 229 | 373 | 7.7E-39 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/66599|m.17334 | UnnamedSample_HQ_transcript/66599 | Coverage 0.762 too low. | 72981c23bc2ad859334760ee6a6c8ace | 228 | Pfam | PF01871 | AMMECR1 | 42 | 211 | 2.4E-48 | T | 22-09-2020 | IPR002733 | AMMECR1 domain |
| UnnamedSample_HQ_transcript/32219|m.10009 | UnnamedSample_HQ_transcript/32219 | Coverage 0.783 too low. | 72981c23bc2ad859334760ee6a6c8ace | 228 | Pfam | PF01871 | AMMECR1 | 42 | 211 | 2.4E-48 | T | 22-09-2020 | IPR002733 | AMMECR1 domain |
| UnnamedSample_HQ_transcript/66522|m.17318 | UnnamedSample_HQ_transcript/66522 | Coverage 0.538 too low. | e4c575a5e4af0b6c10932c15fb8dc7f2 | 523 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 124 | 501 | 4.2E-99 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/113990|m.24299 | UnnamedSample_HQ_transcript/113990 | Coverage 0.943 too low. | 85fab11b4638e0dc8091efff7845c892 | 246 | Pfam | PF07650 | KH domain | 20 | 93 | 4.6E-12 | T | 22-09-2020 | IPR004044 | K Homology domain, type 2 |
| UnnamedSample_HQ_transcript/113990|m.24299 | UnnamedSample_HQ_transcript/113990 | Coverage 0.943 too low. | 85fab11b4638e0dc8091efff7845c892 | 246 | Pfam | PF00189 | Ribosomal protein S3, C-terminal domain | 106 | 188 | 1.4E-22 | T | 22-09-2020 | IPR001351 | Ribosomal protein S3, C-terminal |
| UnnamedSample_HQ_transcript/18395|m.6421 | UnnamedSample_HQ_transcript/18395 | Coverage 0.099 too low. | 9d1fdf645bacca96fb61d6d64ecfc027 | 650 | Pfam | PF00069 | Protein kinase domain | 51 | 305 | 3.2E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/11236|m.4232 | UnnamedSample_HQ_transcript/11236 | Coverage 0.334 too low. | c9bf5ff93dd6fa78fd7d877dc319fde8 | 177 | Pfam | PF00069 | Protein kinase domain | 73 | 175 | 4.9E-18 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/20839|m.7102 | UnnamedSample_HQ_transcript/20839 | Coverage 0.362 too low. | c9bf5ff93dd6fa78fd7d877dc319fde8 | 177 | Pfam | PF00069 | Protein kinase domain | 73 | 175 | 4.9E-18 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/35879|m.10900 | UnnamedSample_HQ_transcript/35879 | Coverage 0.055 too low. | 465d20b8c6315519b1706ee8da3a6371 | 190 | Pfam | PF13855 | Leucine rich repeat | 138 | 190 | 8.2E-13 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/30|m.31 | UnnamedSample_HQ_transcript/30 | Unmapped. | a85e4594ee55b3d83db55d63c4bfb67e | 2017 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 263 | 1.1E-5 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/30|m.31 | UnnamedSample_HQ_transcript/30 | Unmapped. | a85e4594ee55b3d83db55d63c4bfb67e | 2017 | Pfam | PF13087 | AAA domain | 848 | 1019 | 1.9E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/30|m.31 | UnnamedSample_HQ_transcript/30 | Unmapped. | a85e4594ee55b3d83db55d63c4bfb67e | 2017 | Pfam | PF13086 | AAA domain | 665 | 735 | 1.0E-8 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
